UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 11.

Krauer, F; Ahmadli, U; Kollias, S; Bleisch, J; Wüthrich, R P; Serra, A L; Poster, D (2012). Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance. Clinical Kidney Journal, 5(5):405-411.

Pavik, I; Jaeger, P; Ebner, L; Poster, D; Krauer, F; Kistler, A D; Rentsch, K; Andreisek, G; Wagner, C A; Devuyst, O; Wüthrich, R P; Schmid, C; Serra, A L (2012). Soluble Klotho and autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology, 7(2):248-257.

Pavik, I; Jaeger, P; Kistler, A D; Poster, D; Krauer, F; Cavelti-Weder, C; Rentsch, K M; Wüthrich, R P; Serra, A L (2011). Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Kidney International, 79(2):234-240.

Serra, A L; Poster, D; Kistler, A D; Krauer, F; Raina, S; Young, J; Rentsch, K M; Spanaus, K S; Senn, O; Kristanto, P; Scheffel, H; Weishaupt, D; Wüthrich, R P (2010). Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. New England Journal of Medicine, 363(9):820-829.

Serra, A L; Poster, D; Wüthrich, R P (2010). Autosomal-dominante polyzystische Nierenerkrankung : Neue therapeutische Ansätze. Der Nephrologe, 5(5):404-411.

Kistler, A D; Mischak, H; Poster, D; Dakna, M; Wüthrich, R P; Serra, A L (2009). Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney International, 76(1):89-96.

Kistler, A D; Poster, D; Krauer, F; Weishaupt, D; Raina, S; Senn, O; Binet, I; Spanaus, K; Wüthrich, R P; Serra, A L (2009). Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney International, 75(2):235-241.

Kistler, A D; Poster, D; Wüthrich, R P; Serra, A L (2009). Hydronephrosis in autosomal dominant polycystic kidney disease. Kidney International, 76(12):1297.

Poster, D; Kistler, A D; Krauer, F; Blumenfeld, J D; Rennert, H; Weishaupt, D; Wüthrich, R P; Serra, A L (2009). Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series. American Journal of Kidney Diseases, 54(3):450-458.

Serra, A L; Kistler, A D; Poster, D; Krauer, F; Senn, O; Raina, S; Pavik, I; Rentsch, K; Regeniter, A; Weishaupt, D; Wüthrich, R P (2009). Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease. Nephrology, Dialysis, Transplantation, 24(11):3334-3342.

Serra, A L; Kistler, A D; Poster, D; Struker, M; Wüthrich, R P; Weishaupt, D; Tschirch, F (2007). Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study. BMC Nephrology, 8:13.

This list was generated on Fri Jul 28 02:13:11 2017 CEST.